Vancomycin prophylaxis and emerging resistance: Are ophthalmologists the villains? The heroes?

American Journal of Ophthalmology

Volumn 131, Issue 3, 2001, Pages 371-376

  Gordon, Y Jerold ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CATARACT EXTRACTION; COAGULASE NEGATIVE STAPHYLOCOCCUS; COST BENEFIT ANALYSIS; DRUG EFFICACY; ENDOPHTHALMITIS; ENTEROCOCCUS; HUMAN; OPHTHALMOLOGY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STAPHYLOCOCCUS AUREUS;

EID: 0035126339     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(00)00955-7     Document Type: Article

References (38)

1. CDC. Recommendations for preventing the spread of vancomycin resistance. Morb Mort Wkly Rep 1995;44(RR-12):1-13.
2. Gills JP. Filter and antibiotics in irrigating solution for cataract surgery. J Cataract Refrac Surg 1991;17:385.
3. Gimbel HV, Sun R, DeBrof BM. Prophylactic intracameral antibiotics during cataract surgery. The incidence of endophthalmitis and corneal endothelial cell loss. Eur J Implant Refract Surg 1994;6:280-285.
4. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987;316:927-931.
5. Leclerq R, Derlot E, Weber M, Duval J, Couvarlin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. N Engl J Med 1988;319:157-161.
6. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover EC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997;40:135-136.
7. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover EC, Zervos MJ, Band JD, White E, and Jarvis WR. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:494-501.
8. Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999;340:517-523.
9. Kac G, Podglajen I, Buu-Hoi A, Gutmann L, Fagon J. Infections and colonizations due to methicillin-resistant Staphylococcus aureus with decreased-susceptibility to glycoproteins (GISA) in a medical intensive care unit (ICU). 39th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), September 26-29, 1999, San Francisco, CA, Abstract 2083, p. 651.
10. Waldvogel FA. New resistance in Staphylococcus aureus. N Engl J Med 1999;340:557.
11. Fridkin SA. Update on VISA. 40th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), September 17-20, 2000, Toronto, Canada, Abstract 1902, p. 544.
12. Villatoro CRM, Mejia C, Martinez G, Gordillo M, Ramirez C, Aguilera A. High-level resistance of Staphylococcus aureus to vancomycin (VRSA) in Guatemala strains. 39th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), September 26-29, 1999, San Francisco, CA, Abstract 2084, p. 652.
13. Denis O, Nonhoff C, Bobin-Dubreux S, Byl B, Knoop C, Etienne J, Struelens MJ. Emergence of methicillin resistant Staphylococcus aureus (MRSA) with decreased susceptibility to vancomycin in a Belgian hospital. 40th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), September 17-20, 2000, Toronto, Canada, Abstract 1779, p. 106.
14. Heym B, Jurand C, Armand-Lefevre L, Nicholas-Chanoine MH. Outbreak of methicillin resistant Staphylococcus aureus (MRSA) with reduced glycopeptide susceptibility (GISA) in two surgery wards and an intensive care unit (ICU) of a French hospital. 40th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), September 17-20, 2000, Toronto, Canada, Abstract 723, p. 409.
15. Sieradzki K, Tomasz A. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J Bacteriol 1997;179:2557-2566.
16. Cui L, Murakami H, Hanaki H, Kuwahara K, Hiramatsu K. Mechanism of vancomycin resistance expressed by Staphylococcus aureus strain Mu50. 40th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), September 17-20, 2000, Toronto, Canada, Abstract 676, p. 78.
17. van den Bogaard AE, Stobberingh EE. Epidemiology of resistance to antibiotics. Links between animals and humans. Int J Antimicrob Ag 2000;14:327-335.
18. Kirst HA, Thompson DC, Nicas TI. Historical yearly usage of vancomycin. Antimicrob Ag & Chemother 1998;42:1303-1304.
19. Liesegang TJ. Perioperative antibiotic prophylaxis in cataract surgery. Cornea 1999;18:383-402.
20. Masket S. Preventing diagnosing and treating endophthalmitis. J Cataract Refract Surg 1998;24:725-726.
21. Gordon YJ. Antimicrobial prophylaxis in ophthalmic surgery: ritual versus reality. Hawaii '99, January 28, 1999, Big Island of Hawaii, HI.
22. Schmitz S, Dick HB, Krummenauer F, Pfeiffer N. Endophthalmitis in cataract surgery. Ophthalmol 1999;106:1869-1877.
23. Samad A, Solomon LD, Miller MA, Mendelson J. Anterior chamber contamination after uncomplicated phacoemulsification and intraocular lens implantation. Am J Ophthalmol 1995;120:143-50.
24. Ferro JF, De-Pablos M, Logrono MJ. Postoperative contamination after vancomycin and gentamycin during phacoemulsification. Arch Ophthalmol 1997;115:165-170.
25. Feys JF, Salvanet-Bouccara A, Emond J, Dublanchet A. Vancomycin prophylaxis and intraocular contamination during cataract surgery. J Cataract Refrac Surg 1997;23:894-897.
26. Mendívil A, Mendívil MP. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery. Am J Ophthalmol 2000;131:293-300.
27. Alfonso E. Controversies in endophthalmitis prevention. Arch Ophthalmol 1995;113:1369-1370.
28. Townsend-Pico WA, Meyers SM, Langston RHS, Costin. Coagulase-negative Staphylococcus endophthalmitis after cataract surgery with intraocular vancomycin. Am J Ophthalmol 1996;121:318-319.
29. Anonymous. Results of the endophthalmitis vitrectomy study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 1995;113:1479-1496.
30. Donnenfeld ED, Snyder RW. The advantages and disadvan-tages of using vancomycin in the infusion bottle. Therapeutic Updates in Ophthalmology 2000;3:4-5.
31. Gritz DC, Cevallos AV, Smolin G, Whitcher JP. Antibiotic supplementation of intraocular irrigating solutions. An in vitro model of antibiotic action. Ophthalmology 1996;103:1204-1208.
32. Stratton CW, Liu C, Weeks LS. Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against Staphylococci as determined by kill-kinetics a studies. Antimicrob Ag and Chemother 1987;31:1210-1215.
33. Novak R, Henriques B, Charpentier E, Normark S, Tuomanen E. Emergence of vancomycin tolerance in Streptococcus pneumonia. Nature 1999;399:590-593.
34. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996;122:1-17.
35. Axel-Siegel R, Stiebel-Kalish H, Rosenblatt I, Strassmann E, Yassur Y, Weinberger D. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology 1999;106:1660-1664.
36. AAO-CDC Task Force. The prophylactic use of vancomycin for intraocular surgery. Quality of Care Publications, Number 515, American Academy of Ophthalmology, San Francisco, CA, October, 1999.
37. Rybak MJ, Hershberger E, Moldovan T, Grucz RG. In vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob Ag & Chemother 2000;44:1062-1066.
38. Moise PA, Birmingham MC, Forrest A, Schentag JJ. Linezolid use in patients who are intolerant to or fail vancomycin. 40th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), September 17-20, 2000, Toronto, Canada, Abstract 2233, p. 487.